Clinical Trial Update: Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing interleukin-1 blockade after acute myocardial infarction to prevent heart failure is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure | Phase 2 | Status: RECRUITING